Skip to main content
. Author manuscript; available in PMC: 2014 May 21.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Aug 31;4(10):1580–1589. doi: 10.1158/1940-6207.CAPR-11-0036

Table 4.

Compliance*

Treatment N Minimum Maximum Median Mean Std Dev
Celecoxib 75 0.0 101.2 93.3 88.3 15.2
Placebo 65 0.0 107.5 91.0 83.8 20.3

Wilcoxon test p-value=0.18

*

For entire treatment period for each subject